Fernando de Álvaro Moreno, María José Soler, José Luis Górriz Teruel, Alberto Martínez-Castelao, Juan F. Navarro-González, Beatriz Fernandez-Fernandez, Alberto Ortiz, Institut Català de la Salut, [Martínez-Castelao A] Nephrology department, Bellvitge University Hospital, Barcelona, Spain. GEENDIAB (Grupo Español de Estudio de la Nefropatía Diabética), Sociedad Española Nefrología (SEN), Santander, Spain. REDinREN, Instituto Salud Carlos III, Madrid, Spain. [Soler MJ] GEENDIAB (Grupo Español de Estudio de la Nefropatía Diabética), Sociedad Española Nefrología (SEN), Santander, Spain. REDinREN, Instituto Salud Carlos III, Madrid, Spain. Servei de Nefrologia, Vall d'Hebron Hospital Universitari, Barcelona, Spain. [Górriz Teruel JL] GEENDIAB (Grupo Español de Estudio de la Nefropatía Diabética), Sociedad Española Nefrología (SEN), Santander, Spain. REDinREN, Instituto Salud Carlos III, Madrid, Spain. Nephrology department, Hospital Clínico Valencia, INCLIVA, Valencia, Spain. [Navarro-González JF] GEENDIAB (Grupo Español de Estudio de la Nefropatía Diabética), Sociedad Española Nefrología (SEN), Santander, Spain. REDinREN, Instituto Salud Carlos III, Madrid, Spain. Nephrology department, Unidad Investigación Hospital Nuestra Señora de Candelaria, Tenerife, Spain. [Fernandez-Fernandez B] GEENDIAB (Grupo Español de Estudio de la Nefropatía Diabética), Sociedad Española Nefrología (SEN), Santander, Spain. REDinREN, Instituto Salud Carlos III, Madrid, Spain. Nephrology department, IIS-Fundación Jiménez Díaz UAM, Madrid, Spain. [de Alvaro Moreno F] GEENDIAB (Grupo Español de Estudio de la Nefropatía Diabética), Sociedad Española Nefrología (SEN), Santander, Spain. Nephrology department, Hospitales Madrid, Madrid, Spain, and Vall d'Hebron Barcelona Hospital Campus
Diabetis mellitus; Malaltia renal diabètica; Atenció multidisciplinària Diabetes mellitus; Diabetic kidney disease; Multidisciplinary care Diabetes mellitus; Enfermedad renal diabética; Atención multidisciplinaria Age-standardized rates of diabetes mellitus (DM)-related complications, such as acute myocardial infarction, stroke or amputations, have decreased in recent years, but this was not associated with a clear reduction of the incidence of advanced chronic kidney disease (CKD) requiring renal replacement therapy. The early detection of diabetic kidney disease (DKD) is a key to reduce complications, morbidity and mortality. Consensus documents and clinical practice guidelines recommend referral of DM patients to nephrology when the estimated glomerular filtration rate falls below 30 mL/min/1.73 m2 or when albuminuria exceeds 300 mg/g urinary creatinine. Conceptually, it strikes as odd that patients with CKD are referred to the specialist caring for the prevention and treatment of CKD only when >70% of the functioning kidney mass has been lost. The increasing global health burden of CKD, driven in large part by DKD, the suboptimal impact of routine care on DKD outcomes as compared with other DM complications, the realization that successful therapy of CKD requires early diagnosis and intervention, the advances in earlier diagnosis of kidney injury and the recent availability of antidiabetic drugs with a renal mechanism of action and lack of hypoglycaemia risk, which additionally are cardio- and nephroprotective, all point towards a paradigm shift in the care for DM patients in which they should be referred earlier to nephrology as part of a coordinated and integrated care approach. Sources of support: FIS/Fondos FEDER PI18/01386, PI19/00588, PI19/00815, DTS18/00032, ERA-PerMed-JTC2018 (KIDNEY ATTACK AC18/00064 and PERSTIGAN AC18/00071, ISCIII-RETIC REDinREN RD016/0009), Sociedad Española de Nefrología, FRIAT, Comunidad de Madrid en Biomedicina B2017/BMD-3686 CIFRA2-CM.